A phase III study assessing CKD-333 in hypertension and dyslipidaemia
Latest Information Update: 01 Apr 2021
At a glance
- Drugs CKD-333 (Primary)
- Indications Dyslipidaemias; Hypertension
- Focus Therapeutic Use
- Sponsors Chong Kun Dang
- 01 Apr 2021 New trial record